(re-post to insure clarification regarding who has
& has not been approved for a 3rd booster vac-
cination in the U.S.)
Disclaimer / Clarifier 1: Scientists say these findings
need further monitoring and evaluation.
Disclaimer / Clarifier 2: Reported elsewhere, a 3rd
booster vaccination will be needed 6 to 8 months
after one is fully vaccinated, but that has only been
approved in the U.S. for "7 million severely immuno-
compromised people" per following 2 posts:
https://groups.google.com/g/misc.health.diabetes/c/IdVInZEhl8k/m/FuBTZ8_aAQAJ https://groups.google.com/g/misc.health.diabetes/c/IdVInZEhl8k/m/7C9e3_09AgAJ
It has only been approved for the "7 million severely
immunocompromised people" in the U.S. detailed
above, but it has not yet been approved for anyone
else in the U.S. (it has been approved at the 6 month
point in Israel).
- - - - - - - - -
- - -
By Regenstrief Institute September 12, 2021
How Pfizer / Moderna / Johnson & Johnson
COVID-19 Vaccines Compare
https://scitechdaily.com/covid-19-vaccines-effective-against-delta-variant-how-pfizer-moderna-and-jj-compare/
- - -
Data from a national study shows that COVID-19
vaccines are effective at preventing hospitalizations
& emergency department visits caused by the Delta
variant.
COVID-19 vaccines are effective at preventing hos-
pitalizations & emergency department visits caused
by the Delta variant, according to data from a national
study.
That data also indicate that Moderna’s vaccine is sig-
nificantly more effective against Delta than Pfizer &
Johnson & Johnson. “These real-world data show that
vaccines remain highly effective at reducing COVID-19
related hospitalizations & emergency department visits,
even in the presence of the new COVID-19 variant.” ...
“We strongly recommend vaccinations for all who are
eligible to reduce serious illness and ease the burden
on our healthcare system.”
The Centers for Disease Control & Prevention (CDC)’s
VISION Network analyzed more than 32,000 medical
encounters from 9 states during June, July, & August
2021, when the Delta variant became the predominant
strain.
The results showed that unvaccinated individuals with
COVID-19 are 5-7 times more likely to need emergency
department care or hospitalization, similar to the overall
effectiveness prior to the variant.
The study in Morbidity and Mortality Weekly Report is
also the first analysis from the VISION Network to show
a marked difference between the effectiveness of the
mRNA vaccines (Moderna & Pfizer). In the study’s time
period:
o Moderna was 95% effective at preventing hospitaliza-
tions among adults ages 18 and older.
o Pfizer was 80% effective at preventing hospitalizations
among adults ages 18 and older.
o Johnson & Johnson was 60% effective at preventing
hospitalizations among adults ages 18 and older.
The study also found that vaccine effectiveness is lower
for people 75 years & older, which has not been shown
in previous research. This could be due to a range of
factors, including the increased time since vaccination.
When it came to preventing emergency department &
urgent care visits, analysis showed that:
o Moderna was 92% effective.
o Pfizer was 77% effective.
o Johnson & Johnson was 65% effective.
“Despite the differences in effectiveness, vaccines con-
tinue to offer much more protection than not getting one
at all.” ... “While breakthrough cases do happen, data
shows the symptoms are less severe. The vast majority
of COVID hospitalizations & deaths continue to be among
unvaccinated individuals. COVID-19 vaccines are power-
ful tools for combating the pandemic.”
The VISION network, funded by the CDC, includes 7 org-
anizations that contribute & analyze data from U.S. health-
care systems to learn more about the COVID-19 vaccine
effectiveness. In addition to Regenstrief Institute, other
members are
o Columbia University Irving Medical Center,
o HealthPartners,
o Intermountain Healthcare, Kaiser Permanente Northern
California,
o Kaiser Permanente Northwest,
&
o University of Colorado.
...
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Diabetes Bubble / Diabetes Bubble Burst
https://prohuman.net/diabetesbubblediabetesbubbleburst.htm
C.ure I.nsulinitis A.ssociation
https://prohuman.net/cureinsulinitisassociation.htm
Glucose Anomalies Research regarding
Potential Cures / Improvements in Treatments
https://prohuman.net/glucoseanomaliesresearch.htm
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
--- SoupGate-Win32 v1.05
* Origin: fsxNet Usenet Gateway (21:1/5)